Company profile
Conrig Pharma company profile
Conrig Pharma will reposition drug molecules with attractive safety and efficacy profiles through simple modifications and reformulations to provide fast development of new treatments of illnesses. Initial focus will be on a development of a new drug for oral treatment of atopic dermatitis (a type of eczema).
Business identity
- Website
- http://www.conrigpharma.com/
- Contact email
- [email protected]
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2010-01-01
Headquarters
- Headquarters
- Dallgow-Döberitz, Brandenburg, Germany
- Postal code
- 4450
- Country code
- DE
- Continent
- Europe